Hepatitis G virus in clotting factor concentrates

Haemophilia

Volumn 9, Issue 1, 2003, Pages 110-115

  Alonso Rubiano, E ^a   Gerber, M ^a   Friedmann, P ^b   Hodges, S ^b   Leissinger, Cindy ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Clotting factor concentrates; Haemophilia; Hepatitis G.

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; SOLVENT;

ARTICLE; BLEEDING DISORDER; CONTROLLED STUDY; DRUG EFFICACY; DRUG MANUFACTURE; HEMOPHILIA; HEPATITIS B; HEPATITIS C; HEPATITIS G; HEPATITIS G VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTHERMIC THERAPY; NONHUMAN; PASTEURIZATION; PLASMA; PREVALENCE; PRIORITY JOURNAL; UNITED STATES; VIRUS INACTIVATION; VIRUS PURIFICATION; VIRUS TRANSMISSION;

EID: 0037273579     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2003.00706.x     Document Type: Article

References (29)

1. Leary TP, Muerhoff AS, Simmonds JN et al. Sequence and genomic organization of GBV-C a novel member of the Flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996; 48: 60-2.
2. Linnen J, Wages J, Zhangekeck ZY et al. Molecular cloning and disease association of hepatitis G virus. A transfusion transmissible agent. Science 1996; 271: 505-8.
3. Alter H, Nakatsuji Y, Melpolder J et al. The incidence of transfusion associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336: 747-54.
4. Schmidt B, Korn K, Fleckenstein B. Molecular evidence for transmission of hepatitis G virus by blood transfusion. Lancet 1996; 347: 909-10.
5. Aikawa T, Sugei Y, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med 1996; 334: 195-6.
6. Masuko K, Mitsui T, Iwano K et al. Infection with hepatitis GB virus in patients on maintenance hemodialysis. N Engl J Med 1996; 334: 1485-90.
7. Halasz R, Weiland O, Sallberg M. GB Virus/hepatitis G virus. Scand J Infect Dis 2001; 33: 572-80.
8. Garcia T, Lopez A, Quintana M, Hernandez F, Carreno V. HGV in coagulation factor concentrates. Lancet 1996; 348: 1032.
9. DeFilippi F, Columbo N, Rumi M et al. High rates of Hepatitis G virus infection in multitransfused patients with hemophilia. Blood 1997; 90: 4634-7.
10. Hanley J, Jarvis L, Hayes PA, Simmonds P, Ludlman C. Patterns of hepatitis G viraemia and liver disease in hemophiliac patients exposed to non-virus inactivated coagulation factor concentrates. Thromb Hemost 1998; 79: 291-5.
11. Yamada-Osaki M, Sumazaki R, Kajiwara Y. Natural course of HGV in haemophiliacs. Br J Hematol 1998; 102: 616-21.
12. Gerolami V, Halpon P, Chambost H et al. Prevalence of hepatitis G virus RNA in a population of French haemophiliacs. Br J Hematol 1997; 99: 209-14.
13. Mauser E, Marjolen D, Zaaijer H et al. Hepatitis G virus RNA and E2 antibodies in Dutch haemophiliacs patients. Blood 1998; 92: 2164-6.
14. Soucie JM, Robertson BH, Bell BP, Mc Caustland KA, Evatt BL. Hepatitis A virus infections associated with clotting factor concentrates in the United States. Transfusion 1998; 38: 573-9.
15. Kasper CK, Lusher JM and the Transfussion Practices Committee. Recent evolution of clotting factors concentrates for hemophilia A and B. Transfusion 1993; 33: 421-33.
16. Marshall RL, Cockerill J, Friedman P et al. Detection of GB virus by the RT-PCR LCx system. J Virol Methods 1998; 73: 99-107.
17. Bisceglie A. Hepatitis G virus infection, a work in progress. Ann Intern med 1996; 125: 772-4.
18. Lefrere JJ, Mariotti M, Lebrale J, Thauvin M, Girot R. Long term persistence of hepatitis G virus in immunocompetent patients. Lancet 1996; 348: 1174-5.
19. Wang J, Tsai F, Lee C et al. A prospective study of transfusion transmitted GBV virus infection. Similar but different clinical presentation. Blood 1996; 88: 1881-6.
20. Bowden S, Moaven L, Locarni S. New hepatitis viruses; are there enough letters in the alphabet. MJA 1996; 164: 87-9.
21. Alter M, Gallager M, Morris T et al. Acute non A-E hepatitis in the United States and the role oh hepatitis G virus in infection. N Engl J Med 1997; 336: 741-6.
22. Oelsner D, Cadwell SH, Kim JH. Hepatitis G virus prevalence in a cryptogenic cirrhotic population. Gastroenterology 1996; 110: A1282 (letter).
23. Yoshiba M, Okamoto H, Mishiro S. Detection of GBV-C hepatitis genome in serum of patients with fulminant hepatitis of unknown etiology. Lancet 1995; 346: 1131-2.
24. Nubling CM, Lower J. GBV-C genome in a high risk group in plasma pools and intravenous immunoglobulins. Lancet 1996; 347: 68-9.
25. Yeo A, Matsumoto A, Shih J, Alter H, Goedert J. Prevalence of hepatitis G virus in patients with Hemophilia and their steady female sexual partners. Sex Transm Dis 2000; 27: 178-82.
26. Colombo M, Mannicci PM, Cornelli V, Savidge GF, Gazengel C and the European Study Group. Transmission of non-A, non-B hepatitis by heat-treated factor VIII concentrate. Lancet 1985; 24: 1-5.
27. Horowitz MS, Rooks C, Horowitz B, Hilgartner MW. Virus safety of solvent/detergent antihemophiliac factor concentrate. Lancet 1988; 2: 186-9.
28. Morfini M, Longo G, Rossi Ferrini P et al. Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate. The role of parvovirus. Am J Hematol 1992; 39: 149-50.
29. Schimpf K, Mannucci PM, Kreutz W et al. Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions. N Engl J Med 1987; 316: 918-22.